MMP2 and myocardial infarction: In patients with HF with reduced ejection fraction (HFrEF) following an acute MI, clinical studies revealed that treatment with statins, such as Atorvastatin, Rosuvastatin, and Pravastatin, led to reduced serum MMP-2 levels, which were accompanied by lower mortality rates and fewer hospital readmissions [41].